Orbio Raises $1.2M Seed in Robinhood Ecosystem

TL;DR: Orbio raised $1.2 million in seed funding, announced October 10, 2026, according to Bloomingbit, which credits Odaily's report. The company is building a marketplace where users trade discounted credits for access to more than 400 AI models, including Claude Fable and GPT Astra. The investors weren't disclosed, and I haven't seen a filing or a term sheet.

I signed off on more than 1,000 QA jobs in the Navy, and one habit survived the trip into investing. Verify before you trust. Downside first.

Who is behind the $1.2 million, and what is Orbio building?

The investors haven't been named. TokenPost reports that the participating investors or institutions were not disclosed. That's the first thing I'd flag if you're an accredited investor reading a seed headline. A round size tells you what someone paid. It doesn't tell you who paid it, or on what terms.

Orbio's own description has two parts. One is the credit marketplace. The other, per Bloomingbit, is a system that lets AI agents independently secure and configure computing resources, hardware and dedicated high-performance infrastructure. Both come from the company's announcement, and nobody has audited either.

How does the credit marketplace work?

You buy credits at a discount and spend them on model usage through an Orbio API key. Orbio's own site says $100 in credits gives you $100 of model usage through your Orbio key, and that the platform fee is 5% of the discounted credit price. It also advertises under 50 ms of added latency, measured per request. That's the company's number. I couldn't test it.

The site doesn't say why the credits are cheaper, or who supplies them. A discount has to come from somewhere, and until the supplier is named, I'd treat the margin as an open question. Add the 5% fee and you have a fee stack to read before you read the pitch.

What's the token, and why does it complicate a seed round?

This is not a plain equity seed story. TokenPost reports that the ORBIO token was issued through the Pons platform and is backed by a pool of tokenized Nvidia stock. Chainreport adds that about 950 million ORBIO are in circulation on Robinhood Chain, though Orbio's primary documentation doesn't publish a complete token-allocation or vesting schedule.

So there's a $1.2 million round, a live token, and no public picture of who holds how much. I'd want that schedule before forming a view on either one. Nobody has said whether the seed investors hold equity, tokens, or both.

Question	What the reporting says	Status
Amount raised	$1.2 million seed	Reported by Bloomingbit and TokenPost
Date	October 10, 2026	Reported
Investors	Not disclosed	Named gap
Product	Discounted credits for 400+ AI models	Company claim
Token backing	Pool of tokenized Nvidia stock	Reported by TokenPost
Vesting schedule	Not published in primary documentation	Named gap

The table is short on purpose. Most of what you'd want for a diligence file is still blank.

Is Orbio actually part of Robinhood?

The label is "in the Robinhood ecosystem." Nothing reported says Robinhood invested in, owns, or endorses Orbio. Chainreport places the token on Robinhood Chain, which explains the label. Read the phrase as a location and not a partnership.

The backdrop is real, though. Tearsheet reports that Robinhood introduced Robinhood Agents at its September 29 HOOD Summit, and that more than 150,000 customers had opened agentic trading accounts by the end of September. That's demand for AI agents inside Robinhood's own products. It says nothing about whether Orbio captures any of it.

What does this mean for an accredited investor?

For most readers, there's nothing to act on. No reporting describes an offering you could join. What you can do is practice the diligence on a small case, which is cheaper than practicing it on a large one.

Run it the way I'd run any deal. The sponsor is the investment, and here the sponsor is unnamed. Illiquidity is a cost, and a token with no published vesting gives you no way to price it. A discount with no stated supplier is a fee stack you can't read yet. If you want the small end of AI funding with named investors and clearer reporting, our piece on Quotr's $4M seed round is a better comparison.

If you're newer to reading seed headlines, start with how much seed rounds raise and who writes the check. For the opposite end of the market, see why mega-rounds lock out solo angels.

I'll be watching three things. Does Orbio name its investors? Does it publish token allocation and vesting? Does the credit discount come with a stated supplier? Until those are answered, the round size is the least useful number in the story.

Common mistakes when reading a seed headline like this

The first is treating an ecosystem label as an endorsement. Being on a chain or near a brand doesn't mean that brand has backed the project.

The second is reading round size as quality. $1.2 million is small, and it says nothing about whether the product works.

The third is trusting a repeated report. Bloomingbit and TokenPost both trace to the same announcement, so two outlets isn't two independent confirmations. Get the original announcement or a filing.

FAQ

How much did Orbio raise? Orbio raised $1.2 million in seed funding, announced October 10, 2026, according to Bloomingbit and TokenPost. The investors weren't disclosed.

What does Orbio do? It's building a marketplace for discounted credits covering more than 400 AI models, per Bloomingbit. It also says it's developing a system that lets AI agents configure computing resources themselves.

Can accredited investors invest in Orbio? No reporting describes any offering to investors. The round has closed, and the ORBIO token is a separate instrument with no published vesting schedule. This article isn't a recommendation to buy either.

Is Orbio owned by Robinhood? Nothing in the reporting says so. It describes Orbio as a project in the Robinhood ecosystem, and Chainreport places its token on Robinhood Chain.

If you want this kind of downside-first read on private-market deals in your inbox, sign up for the free AIN briefing.

Educational content only. Not investment, tax, or legal advice. Not an offer or solicitation to buy or sell securities. Past performance does not guarantee future results. Private-market investments are illiquid and involve risk of loss, including total loss of capital. Consult qualified advisers. Angel Investors Network is not a broker-dealer or investment adviser.